199 related articles for article (PubMed ID: 15462267)
1. Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues.
Harvey D; Lowe GM
Br J Biomed Sci; 2004; 61(3):157-64. PubMed ID: 15462267
[TBL] [Abstract][Full Text] [Related]
2. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden: a disorder of factor V anticoagulant function.
Castoldi E; Rosing J
Curr Opin Hematol; 2004 May; 11(3):176-81. PubMed ID: 15257017
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
5. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor V and thrombophilia: background and mechanisms.
Segers K; Dahlbäck B; Nicolaes GA
Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden and activated protein C resistance.
Segers O; Castoldi E
Adv Clin Chem; 2009; 49():121-57. PubMed ID: 19947358
[TBL] [Abstract][Full Text] [Related]
11. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
De Stefano V; Leone G
Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
[TBL] [Abstract][Full Text] [Related]
12. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
Tans G; Nicolaes GA; Rosing J
Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
14. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
Simkova M; Simko F; Kovacs L
Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
[TBL] [Abstract][Full Text] [Related]
15. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
16. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
17. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism during pregnancy is not associated with persistent elevated activated protein C (APC) sensitivity ratio based on the endogenous thrombin potential.
Zotz RB; Gerhardt A; Kluft C; Scharf RE
Thromb Haemost; 2005 Feb; 93(2):306-10. PubMed ID: 15711747
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
[TBL] [Abstract][Full Text] [Related]
20. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]